Introduction

Whilst clinical advances allow more people to survive a cancer diagnosis, [1, 2] many cancers are detected at a later stage of the disease where treatment goals are palliative as the diagnosis is incurable. An advanced cancer diagnosis has been recognised as a risk factor for anxiety and depression [3,4,5], which is concerning as psychosocial morbidities may result in treatment non-adherence, poorer quality of life, longer inpatient episodes, and negative impacts on family [6]. Providing optimal care is essential to ensure patients with life-limiting diagnoses are able to experience optimal quality of life.

Living with advanced cancer

Systematic reviews in this area have identified that living with advanced cancer is a complex process, affected by an individual’s support network, personal coping strategies, and attitudes towards their diagnosis [7, 8]. Garcia-Rueda et al. [7] found that ‘health context’ was another prominent theme, which encompasses the ‘hospitalisation experience’ and their ‘experience of healthcare access’.

The health context

Garcia-Rueda et al. [7] found that patient-clinician relationships are important elements of patient experiences within the health system. These could be targeted to improve patient quality of life by providing personalised care that acknowledges the unique challenges faced by people with life-limiting illnesses [9,10,11,12,13,14]. These findings have subsequently been built upon by an increase in qualitative research that explores patient perceptions of early palliative care interventions, seeking to address psychosocial distress people with advanced cancer may experience [15,16,17,18,19,20,21]. These studies have been undertaken predominantly in the USA and in European settings, and consistently identify coordination of care to be an issue in health systems where patient care involves multiple services.

Few qualitative studies have explored the lived experiences of Australians with advanced cancer. In 2018, Chambers et al. [22] found that the experiences of men living with advanced prostate cancer were mediated by their life course and social and health context, and identified a need for holistic approaches to care to address issues related to patient-clinician communication and care coordination. An understanding of patient experiences navigating the health system provides a foundation for understanding how existing resources are meeting patient needs, and identifying areas for improvement.

To our knowledge, there have been no studies examining the experiences of people living with advanced cancer in Western Australia. The health context for cancer care in Western Australia is presented in Table 1. Understanding the role the health system plays in the experiences of people with advanced cancer is essential to identify and address priority issues. This study aimed to explore the lived experiences of people with advanced cancer, focussing on their interactions with the health system and health professionals.

Table 1 The health context in Western Australia: coordination of cancer care

Materials and methods

Design

A descriptive phenomenological approach was used to explore the lived experiences of people with advanced cancer [23]. Van Manen [24] describes phenomenology as a means to interpret, understand, and reflect on participants’ lived experiences that facilitates a more complete understanding of what patients go through. Methods for recruitment and data collection are described elsewhere [25].

Recruitment

Adults attending a medical oncology appointment relating to an advanced solid tumour diagnosis (advanced cancer defined as stage IV, metastatic, or recurrent, or receiving palliative care) were invited by their oncologist to take part in the study. Participants who gave verbal consent to be contacted were followed up by a researcher, who obtained written informed consent and arranged an audio-recorded interview. People receiving care for a haematological malignancy or those with cognitive impairment, defined as a score less than 7 on the Abbreviated Mental Test, were ineligible. The researcher administered the Abbreviated Mental Test before the interview. Haematological malignancies were excluded because treatment and disease progression are different from solid tumour malignancies [26]. A purposive sampling strategy was used (Table 2), and recruitment occurred until inductive thematic saturation was reached across the data.[27], defined as when no new themes arose within the interviews. Analysis occurred concurrently to the interviews to identify when no new themes arose from the interviews.

Table 2 Steps taken to establish rigour in qualitative research [29]

Data collection

An interview guide (Supplement A) was developed with input from all investigators and from consumer representatives. Questions were developed to explore individuals’ needs and explore the emotional, mental, spiritual, and social support participants used following their diagnosis. Interviews were conducted by author JN over the phone (n = 13), at their home (n = 7), or at their treating hospital (n = 3). Some participants had their partners present during part of their interviews. The interviewer has experience conducting qualitative interviews with cancer patients and was supervised by two team members with extensive qualitative research experience. The interviewer was a female PhD student who was not involved with participants’ care, and explained the research was part of her PhD.

Analysis

Interviews were transcribed verbatim and coded in QSR International’s NVivo 12 software. Braun et al.’s [28] methodology for thematic analysis was used to analyse the data. Author JN read and reread the transcripts, coding participants’ experiences using an inductive coding approach. Codes were reviewed within and between transcripts and refined into key themes that described participant experiences. Authors MO and GH reviewed the coding schema and investigator triangulation was used to develop and finalise the coding structure. Discrepancies were resolved via discussion to reach a consensus on the finalisation of codes and themes. Themes were reviewed by all authors. Quotes presented in the results are numbers assigned to each participant’s interview, to deidentify them.

Rigour

Bradshaw et al.’s [29] measures for establishing credibility, confirmability, dependability, and transferability were adhered to throughout this study (see Table 2). The consolidated criterion for reporting qualitative research checklist (COREQ) informed study reporting [30].

Ethics

This project received approval from the Sir Charles Gairdner and Osborne Park Health Care Group Human Research Ethics Committee (#RGS3400), St John of God Health Care Human Research Ethics Committee (#1609), and the Curtin University Human Research Ethics Office (#HRE2019-0725). The data that support the findings of this study are available from the corresponding author upon reasonable request.

Results

Thirty-three eligible participants were identified between February and April 2020, of whom 25 consented. Eight refused participation as they were not interested/did not have time. Two people subsequently withdrew due to a lack of interest in continuing. The remaining 23 participants were interviewed. Demographic information is presented in Table 3.

Table 3 Participant characteristics

Participant experiences living with advanced cancer led to the emergence of three key themes: (1) living with a life-limiting diagnosis and uncertainty, (2) living with symptom burden and side effects, and (3) living within the health system, with two subthemes, the patient-clinician relationship, and care coordination.

Living with a life-limiting diagnosis and uncertainty

All participants were aware they had an incurable cancer diagnosis. They used a variety of methods to cope with their prognosis and the uncertainty; including reframing, milestones, and maintaining autonomy by finding areas of their life they could control. There was a desire for prognostic information from their oncologists, to prepare for the impact of their death on their family. Most participants had been told that they had 3 to 24 months left to live; but a few participants did not know/disclose their prognosis. Not all participants had come to terms with their prognosis.

I’m not happy at all, I got to learn to live with it, but it’s not as easy as people think (P003)

It was particularly hard for participants who had to leave employment, and/or had young adult children.

I actually like working because it took my mind off being sick, I didn’t want to stay at home and be like “poor me, I’ve got cancer” … at least at work I didn’t have to think about it (P010).

Many participants who had been given short prognoses used milestones, such as family events, to reframe the way they viewed the future.

I had set in my mind that I was going to die within six months because they only gave me six months to live … and then one of the nurses said to me: “they tell that to all the stage four cancer patients”. And she said “just fight for as long as you can.” And just by her telling me that, I got it out of my mind and I got a little glimmer of hope that maybe I was going to live past the six months. And when I went past the six months, I started looking forward to the next six months. And I started setting things like my grandchildren’s birthdays….as goals to get to. I’m still doing that now. (P020).

When discussing the nature of their prognosis, some participants used the uncertainty to positively frame their prognosis.

Having a terminal diagnosis, most of the time –no one knows when they’re going to die anyways….you could walk out onto the street and get hit by a car, so most of the time that’s how I think about it. (P015).

A participant who had not received a prognosis wanted to know more from their oncologists, seeking clarity to be able to plan ahead:

I don’t care if he says I’m going to die next week. I’d rather hear that than get some bullshit and then I just drop dead… I’m being a bit sarcastic here, but I want some more clarity and see where I’m going because I’ve got to consider my wife’s situation and … the rest of my life that I’ve got. (P007).

Participants’ experiences coming to terms and living with a terminal prognosis demonstrated that in addition to their personal coping strategies, their family and friends (Table 4) and health professionals have an opportunity to significantly affect their experiences.

Table 4 Quotes demonstrating subtheme 3.1.1: living with a life-limiting illness and its impact on others

Living with symptom burden and side effects

A broad range of cancer diagnoses were represented. Symptoms reported included breathlessness, fatigue, diarrhea, vertigo, nausea and vomiting, pain, neuropathy, insomnia, and loss of appetite; and these were attributed to both diagnosis and treatment. Whilst some participants were being seen by community palliative care services, not all had access to these or were unaware of them and their value in managing their symptoms.

Some participants considered the side effects of chemotherapy ‘worth it’, to enjoy quality of life between treatments:

I have to go through it otherwise I don’t give myself a chance at all of beating this or having a delayed end to my life (P007)

One participant commented that seeking help to manage their symptoms following treatment was difficult when experiencing a high symptom burden.

Sometimes when you have this treatment you are not well enough and you can’t make an effort. If somebody rings you, you can say look that’s how I’m feeling, and then the other person can say okay we can do this for you. So you need it coming from outside look we are there if you need us, rather than the patient trying to find who can I ring? Where can I go? That’s hard. (P025).

Some participants were “frightened” by the prospect of engaging with palliative care.

Palliative care was only something I’d ever heard of at the end of people’s lives so that was a frightening few days waiting to go to see the [oncologist and discuss my treatment plan]. (P021).

Living within the health system

The patient-clinician relationship

Participants’ relationships with their clinicians and health professionals were important. One participant acknowledged the power differential created once they received a life-limiting diagnosis.

When this all came about I said that I would throw myself at the feet of the people that know this and deal with this. Give them the best chance to succeed without interfering. (P005).

There was wide variation in participants’ experiences with health professionals. Some participants appreciated a frank and open relationship with their oncologist.

[they’ve] been a good sport, and that’s what I like. It’s up front, it’s honest. Might hurt when you walk away, but that’s how you want it. (P014)

Another participant, whose oncologist referred them to see a psychologist to deal with the anxiety they felt around discussing test results, appreciated that their oncologist was proactive in managing their care and wellbeing.

I didn’t think about [it] at the time, but I realised that [my oncologist] knew that at some stage there wasn’t going to be a good scan and [they] knew I wasn’t going to cope. Bad enough when I’m getting a good scan, what am I going to be like when I get a bad scan?…[They’ve] got great foresight. (P021).

Other participants reported paternalistic attitudes and poor interpersonal communication:

I did not find much joy talking to the doctors. To me, to get better somebody has to show you [they] are caring about you. But I was just another number … if you don’t have any caring attitude from the doctor, you think [they] are not interested in me because [they] think I am going to die in six months’ time. (P025).

Some participants felt excluded from conversations about them and their care, whilst waiting for test results/treatment plans:

When you see them standing ten yards away and they’re talking and they’re looking straight at you, you’re not part of the conversation. Sometimes you’d like to know exactly what they’re talking about. (P032).

These negative or positive experiences were often exacerbated by the coordination of care that participants experienced whilst navigating the health system.

Care coordination

Participants who needed to attend multiple hospitals, or multiple departments within a hospital for treatment, indicated they felt that the lack of clear communication between hospitals and health professionals had a negative impact on their care.

I didn’t realise that the hospitals didn’t talk to each other, and as the patient that would be my job … I said to [the urologist], can you ring my oncologist and let them know that I don’t need the tests, and I can start treatment again? And he said “yep”, and I went to the oncologist and I [said] “did they ring you?” And they [said] “no”. And I [thought] here we go again. (P010).

Another participant struggled when their health professionals did not see eye-to-eye about who was responsible for their pain management.

I had to fight to get pain relief. And even then it was between the other GP that I was going to and the urologist, it was like I was the meat between the sandwich. She does it, he does it, she does it… It was an awful position to be in. (P020).

Despite their advanced diagnosis, some participants experienced long delays between getting their diagnosis, being referred and seen by an oncologist. The time from diagnosis to treatment ranged from 2 weeks to 6 months. Issues experienced by participants included needing to see multiple GPs to find someone who could refer them to a clinical trial, or referrals not being followed up.

The surgeon that performed the pleurodesis and told me the diagnosis, [told me to] shake hands and say goodbye. So, that was a very devastating time, it was about 6 months we were in extreme distress … I just couldn’t believe that that was it, so we persisted and asked to be referred to an oncologist. (P033).

Participants whose treatment did not involve multiple hospital departments, or, who had a “good ally” in their GP, found navigating the health system easier.

[My GP has] bent over backwards from day one … he seems to have all the right contacts (P007)

Despite seeking care for advanced cancer in a developed country with established care pathways, participant experiences indicate there are substantial gaps in care coordination that need to be addressed.

Discussion

These findings provide an understanding of participants’ experiences living with advanced cancer whilst engaging with the Australian health system. We found that our key themes of living with advanced cancer and living with symptom burden fit into Arantzamendi et al.’s [31] framework for living well with the awareness of dying. This framework describes living with advanced cancer as an iterative process comprising five phases—struggling, accepting, living with advanced cancer, sharing the illness experience, and reconstructing life—all of which revolve around the central concept of awareness of dying. Our key themes of living with advanced cancer and uncertainty, and living with symptom burden and side effects, reflect these phases and people’s complex and unique experiences. Our participants’ discussion about their symptom burden in the context of this framework illustrates their pervasive awareness of dying and highlights the important role symptom control plays in patient experiences. The role of formal and informal support in participant experiences has been discussed elsewhere [25].

Our results from a heterogenous group of Western Australians living with advanced cancer were similar to those reported by Chambers et al. [22], who examined the experiences of Australian men diagnosed with prostate cancer, with regard to communication and care coordination. These commonalities suggest that the issues patients face navigating the health system may not be diagnosis- or stage-specific. The varied experiences of navigating care indicate an urgent need for additional support and resources at the patient, health professional, and system level.

Participant interactions with their health professionals emphasise the importance of shifting from approaching care using the disease-based biomedical model to patient-centred care. Patient-centred care has been defined as care that is “respectful of and responsive to individual patient preferences, needs, and values and [ensures] that patient values guide all clinical decisions” [32]. It has been recognised that good communication between patients and health professionals is an essential component for eliciting patient values to guide patient-centred care [33]. We found that participants appreciated clear communication with and between their health professionals, and their experiences demonstrate the significant impact patient-clinician communication had on their perceptions of their care.

Patient-clinician relationships in which clinicians proactively referred patients or had time to speak to them about their diagnosis/treatment had a positive impact on participants’ psychosocial wellbeing. Instances in which patients felt no health professionals were taking responsibility for their cancer care or where clinicians did not have time to discuss their diagnosis and treatment regimen were distressing and compounded the negative emotions the patients were already experiencing due to their terminal illness. Poor patient-clinician relationships have been associated with demoralisation in advanced cancer patient populations [34], and greater out-of-pocket expenses [35]. Reasons for a breakdown in communication may include patient-related factors such as health literacy; clinician-related factors such as inter-professional communication issues; and system-related issues, such as lack of time [36]. Patient-reported outcome measures (PROMs) have been recognised as a means to encourage patient-clinician discussion of their symptoms and care, and improve patient-clinician communication [37]. In Australia, The Commission on Safety and Quality in Health Care is currently working to support the implementation and evaluation of PROMs. System-wide implementation of a PROMs’ program within Australia suggests that the program is feasible [38]; however, barriers include the impact on clinical workflow, time for completion inadequate resources, and outcome follow-up [38]. Further research into the implementation and efficacy of PROMs’ programs is necessary to determine if they can bridge gaps in patient-clinician communication.

Participant reports of limited time with clinicians to satisfy their information needs and an inability to access allied health professionals are indicators that staffing and care coordination within the health system need to be assessed. Given that Western Australia has a Cancer Nurse Coordinator Service available to all residents navigating cancer care, ensuring they are adequately resourced is necessary. Previous studies have confirmed the positive impact of nurse-led support programs on cancer care e.g., improved quality of life and reduced hospital readmission rates [39]. Internationally, a systematic review of current literature exploring health professionals’ perceptions of care coordination recommended that health systems needed to (1) develop and provide better educational materials and guidelines for health professionals involved in care coordination, (2) ensure health services have adequate staff, administrative support, technology, and resources to coordinate care, and (3) conduct research to examine current care coordination practices to develop and test tools to help develop shared care plans for patients [40]. Adequate resources for health services are essential for clinicians and staff to be supported to provide well-coordinated care. The recommendations resulting from this study are outlined in Table 5. Further research is necessary to quantify how health services are currently meeting the needs of people with advanced cancer, to ensure existing services are adequately resourced, and to inform future service-level interventions to improve patient care coordination.

Table 5 Recommendations to improve patient experiences navigating the health system based on the project’s key findings

Limitations

The generalisability of these findings should be considered within the limitations of this study. Whilst data saturation was achieved, recruitment involved clinician referral resulting in recruitment bias. However, due to the wide variation in participant experiences, this bias appears to be minimal. Whilst most participants noted the significant impact of their diagnosis on their carers, the carers were not interviewed as part of this study. Further research examining the experiences of carers and their support needs is necessary. Finally, we note that there was limited discussion of spirituality and its impact on patient experiences. There was only one question in the interview guide asking participants about the role of spiritual support. Given the prominence of spirituality in the experiences of people with advanced cancer in other research, this could be explored further in future research.

Conclusions

Participant experiences living with advanced cancer are characterised by three key themes: (1) living with a life-limiting diagnosis and uncertainty, (2) living with symptom burden and side effects, and (3) living within the health system. The important role the patient-health professional relationships played in the experiences of people with advanced cancer highlights the value of patient-centred care to support patients with a life-limiting cancer diagnosis. Further attention to the coordination of care for people with advanced cancer is necessary to improve their experiences and the management of their psychosocial burden.